isoproterenol and n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester

isoproterenol has been researched along with n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, JJ; Chen, LZ; Chen, X; Gao, Z; Gong, YS; Huang, WJ; Wang, LX; Zhang, HQ; Zhou, H; Zhou, X1

Other Studies

1 other study(ies) available for isoproterenol and n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester

ArticleYear
Relaxin inhibits cardiac fibrosis and endothelial-mesenchymal transition via the Notch pathway.
    Drug design, development and therapy, 2015, Volume: 9

    Topics: Animals; Cardiomyopathies; Cell Movement; Cells, Cultured; Collagen; Dipeptides; Disease Models, Animal; Endothelial Cells; Epithelial-Mesenchymal Transition; Fibrosis; Human Umbilical Vein Endothelial Cells; Humans; Isoproterenol; Male; Myocardium; Neovascularization, Physiologic; Rats, Sprague-Dawley; Receptor, Notch1; Relaxin; Signal Transduction; Ventricular Function, Left

2015